Edwards Lifesciences Corp (EW) Financials
Key financial figures for Edwards Lifesciences Corp (Q2 2026).
- Revenue
- $1.7B
- Net Income
- $241M
- EPS
- $0.42
- Total Assets
- $13.9B
- Operating Cash Flow
- $652M
Full income statement, balance sheet, and cash flow for Edwards Lifesciences Corp on SentiSense.